Global Esoteric Testing Market

Esoteric Testing Market Size, Share, Growth Analysis, By Technology (DNA Sequencing and Next-Generation Sequencing, Flow Cytometry), By Type (Autoimmune Disease Testing, Infectious Disease Testing), By Specimen (Blood, Serum, and Plasma, Urine), By End User (Independent and Reference Laboratories, Hospital-Based Laboratories), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35A2910 | Region: Global | Published Date: November, 2024
Pages: 206 | Tables: 72 | Figures: 72

Esoteric Testing Market Competitive Landscape

A notable example of a strategic partnership in the esoteric testing market is between Quest Diagnostics and Memorial Sloan Kettering Cancer Center (MSKCC). This collaboration focuses on advanced oncology testing and includes Quest's lab capabilities expands its MSKCC expertise in cancer genomics. Together, it has developed research that helps identify genetic mutations and abnormalities associated with various cancers, and helps physicians develop personalized treatment plans.

Top Player’s Company Profiles

  • LabCorp (US) 
  •  
  •  
  • Quest Diagnostics (US) 
  • OPKO Health, Inc. (US) 
  • H.U. Group Holdings, Inc. (Japan) 
  • Sonic Healthcare Limited (Australia) 
  • Mayo Foundation for Medical Education and Research (MFMER) (US) 
  • Eurofins Scientific (Luxembourg) 
  • Stanford Health Care (US) 
  • Kindstar Globalgene Technology, Inc. (China) 
  • Georgia Esoteric & Molecular Laboratory, LLC (US) 
  • ACM Global Laboratories (US) 
  • NMS Labs (US) 
  • Healthquest Esoterics (US) 
  • Cerba Xpert (France) 
  • Leolabs, Inc. (US) 
  • Flow Health (US) 
  • Invitae Corporation (US) 
  • Myriad Genetics, Inc. (US) 
  • Arup Laboratories (US) 
  • Fulgent Genetics (US) 
  • Biomontr Labs (US) 
  • Labgenomics (South Korea)
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Esoteric Testing Market size was valued at USD 30.1 billion in 2022 and is poised to grow from USD 32.69 billion in 2023 to USD 63.25 billion by 2031, growing at a CAGR of 8.60% during the forecast period (2024-2031).

A notable example of a strategic partnership in the esoteric testing market is between Quest Diagnostics and Memorial Sloan Kettering Cancer Center (MSKCC). This collaboration focuses on advanced oncology testing and includes Quest's lab capabilities expands its MSKCC expertise in cancer genomics. Together, it has developed research that helps identify genetic mutations and abnormalities associated with various cancers, and helps physicians develop personalized treatment plans. 'LabCorp (US) ', ' ', ' ', 'Quest Diagnostics (US) ', 'OPKO Health, Inc. (US) ', 'H.U. Group Holdings, Inc. (Japan) ', 'Sonic Healthcare Limited (Australia) ', 'Mayo Foundation for Medical Education and Research (MFMER) (US) ', 'Eurofins Scientific (Luxembourg) ', 'Stanford Health Care (US) ', 'Kindstar Globalgene Technology, Inc. (China) ', 'Georgia Esoteric & Molecular Laboratory, LLC (US) ', 'ACM Global Laboratories (US) ', 'NMS Labs (US) ', 'Healthquest Esoterics (US) ', 'Cerba Xpert (France) ', 'Leolabs, Inc. (US) ', 'Flow Health (US) ', 'Invitae Corporation (US) ', 'Myriad Genetics, Inc. (US) ', 'Arup Laboratories (US) ', 'Fulgent Genetics (US) ', 'Biomontr Labs (US) ', 'Labgenomics (South Korea)'

One of the major drivers of the esoteric testing market is the rise in chronic diseases such as cancer, cardiovascular diseases and diabetes. These conditions require advanced approaches to detect biomarkers, genetic changes and molecular changes. Esoteric testing provides specialized testing that goes beyond routine diagnosis, essential for early diagnosis and personalized treatment.

Shift to a More Personalized and Precise Treatment: A major trend in the esoteric testing market is the increasing adoption of personalized and accurate medications. With advances in genomics and molecular diagnostics healthcare providers are moving towards personalized medicine tailored to each patient’s individual characteristics. Occult analysis plays a key role in this shift, enabling deeper insights into patient genetics of materials, enabling customized therapeutic regimens.

North America region in the market accounted for 31.22% in 2023. Government subsidies for high quality healthcare, availability of coverage, increased purchasing power, increased incidence of infections and diseases such as cancer are important enhancers in this category. This can be attributed to the anticipated growth of the market owing to well-established healthcare infrastructure, increased purchasing power and moving occult test approval rates. The esoteric testing market in the U.S. is expected to grow slightly and is expected to increase during the forecast period owing to healthcare initiatives, rising prevalence of diabetes and favorable conditions for market expansion in the country.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Esoteric Testing Market

Report ID: SQMIG35A2910

$5,300
BUY NOW GET FREE SAMPLE